Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Fabbri

Showing results (201-210 of 438) with videos related to

Pageof 44
Sort By:
ERJ Open Research|September 18, 2018
Use of adjunct cardiovascular therapy in patients hospitalised for acute exacerbations of COPDSara Roversi, Roberto Tonelli, Bianca Beghè, et al.
American Journal of Respiratory and Critical Care Medicine|May 8, 2004
T cell-based tracking of multidrug resistant tuberculosis infection after brief exposureLuca Richeldi, Katie Ewer, Monica Losi, et al.
Lancet (London, England)|September 1, 2009
Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trialsPeter M A Calverley, Klaus F Rabe, Udo-Michael Goehring, et al.
Respiratory Research|October 31, 2013
Characterisation of exacerbation risk and exacerbator phenotypes in the POET-COPD trialKai M Beeh, Thomas Glaab, Susanne Stowasser, et al.
Lancet (London, England)|February 17, 2015
Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trialFernando J Martinez, Peter M A Calverley, Udo-Michael Goehring, et al.
British Journal of Pharmacology|February 1, 1992
Increase in vascular permeability produced in rat airways by PAF: potentiation by adrenalectomyP Boschetto, F G Musajo, L Tognetto, et al.
The European Respiratory Journal|May 7, 2013
FAQs about the GOLD 2011 assessment proposal of COPD: a comparative analysis of four different cohortsAlvar Agusti, Suzanne Hurd, Paul Jones, et al.
Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology|July 1, 1984
Control of neurotransmission by prostaglandins in canine trachealis smooth muscleE H Walters, P M O'Byrne, L M Fabbri, et al.
Thorax|January 22, 2008
Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitationE Crisafulli, S Costi, F Luppi, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 1, 1989
Ketotifen does not inhibit asthmatic reactions induced by toluene di-isocyanate in sensitized subjectsL Tossin, P Chiesura-Corona, L M Fabbri, et al.
Pageof 44

Showing results (201-210 of 438) with videos related to

Sort By:
Pageof 44
ERJ Open Research|September 18, 2018
Use of adjunct cardiovascular therapy in patients hospitalised for acute exacerbations of COPDSara Roversi, Roberto Tonelli, Bianca Beghè, et al.
American Journal of Respiratory and Critical Care Medicine|May 8, 2004
T cell-based tracking of multidrug resistant tuberculosis infection after brief exposureLuca Richeldi, Katie Ewer, Monica Losi, et al.
Lancet (London, England)|September 1, 2009
Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trialsPeter M A Calverley, Klaus F Rabe, Udo-Michael Goehring, et al.
Respiratory Research|October 31, 2013
Characterisation of exacerbation risk and exacerbator phenotypes in the POET-COPD trialKai M Beeh, Thomas Glaab, Susanne Stowasser, et al.
Lancet (London, England)|February 17, 2015
Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trialFernando J Martinez, Peter M A Calverley, Udo-Michael Goehring, et al.
British Journal of Pharmacology|February 1, 1992
Increase in vascular permeability produced in rat airways by PAF: potentiation by adrenalectomyP Boschetto, F G Musajo, L Tognetto, et al.
The European Respiratory Journal|May 7, 2013
FAQs about the GOLD 2011 assessment proposal of COPD: a comparative analysis of four different cohortsAlvar Agusti, Suzanne Hurd, Paul Jones, et al.
Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology|July 1, 1984
Control of neurotransmission by prostaglandins in canine trachealis smooth muscleE H Walters, P M O'Byrne, L M Fabbri, et al.
Thorax|January 22, 2008
Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitationE Crisafulli, S Costi, F Luppi, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 1, 1989
Ketotifen does not inhibit asthmatic reactions induced by toluene di-isocyanate in sensitized subjectsL Tossin, P Chiesura-Corona, L M Fabbri, et al.
Pageof 44